TIMP3 downregulation was further confirmed by immunohistochemistry (IHC) test of CRC tissues (Fig. 5D) and Q‐PCR analysis in CRC cell lines (Fig. 5E). This evidence concerns the gene TIMP3 and colorectal carcinoma.